{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:43:08Z","timestamp":1781898188388,"version":"3.54.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11064-025-04397-9","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T08:55:21Z","timestamp":1745052921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Oxytocin Anti-Apoptotic Potential Mediates Neuroprotection Against 3-Nitropropionic Acid-Induced Huntington\u2019s Disease-Like Pathophysiology in Rats: Involvement of Calpain-2\/p25 Cdk5\/MEF-2 Signaling Pathway"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0253-4821","authenticated-orcid":false,"given":"Marwa","family":"Rabie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia M.","family":"El-Tanbouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa A.","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmy M.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"4397_CR1","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2174\/1389450122666210224105945","volume":"22","author":"A Sharma","year":"2021","unstructured":"Sharma A, Behl T, Sharma L, Aelya L, Bungau S (2021) Mitochondrial dysfunction in Huntington\u2019s disease: pathogenesis and therapeutic opportunities. Curr Drug Targets 22:1637\u20131667. https:\/\/doi.org\/10.2174\/1389450122666210224105945","journal-title":"Curr Drug Targets"},{"key":"4397_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, Zugno E, Caletti E (2017) Neuropsychiatric burden in Huntington\u2019s disease. Brain Sci 7:67\u201381. https:\/\/doi.org\/10.3390\/brainsci7060067","journal-title":"Brain Sci"},{"key":"4397_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1566-2772(00)00014-1","volume":"1","author":"CA Ross","year":"2001","unstructured":"Ross CA, Margolis RL (2001) Huntington\u2019s disease. Clin Neurosci Res 1:142\u2013152. https:\/\/doi.org\/10.1016\/S1566-2772(00)00014-1","journal-title":"Clin Neurosci Res"},{"key":"4397_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s11064-021-03521-9","volume":"47","author":"H Khan","year":"2022","unstructured":"Khan H, Garg N, Singh TG, Kaur A, Thapa K (2022) Calpain inhibitors as potential therapeutic modulators in neurodegenerative diseases. Neurochem Res 47:1125\u20131149. https:\/\/doi.org\/10.1007\/s11064-021-03521-9","journal-title":"Neurochem Res"},{"key":"4397_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/NDT.S78226","volume":"11","author":"A Yildiz-Unal","year":"2015","unstructured":"Yildiz-Unal A, Korulu S, Karabay A (2015) Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatr Dis Treat 11:297\u2013310. https:\/\/doi.org\/10.2147\/NDT.S78226","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4397_CR6","doi-asserted-by":"publisher","first-page":"1030639","DOI":"10.3389\/fnmol.2022.1030639","volume":"15","author":"Z Tian","year":"2022","unstructured":"Tian Z, Feng B, Wang XQ, Tian J (2022) Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders. Front Mol Neurosci 15:1030639\u20131030656. https:\/\/doi.org\/10.3389\/fnmol.2022.1030639","journal-title":"Front Mol Neurosci"},{"key":"4397_CR7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1042\/bst0290684","volume":"29","author":"M Schuler","year":"2001","unstructured":"Schuler M, Green D (2001) Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29:684\u2013688. https:\/\/doi.org\/10.1042\/bst0290684","journal-title":"Biochem Soc Trans"},{"key":"4397_CR8","doi-asserted-by":"publisher","first-page":"109394","DOI":"10.1016\/j.mehy.2019.109394","volume":"133","author":"KU Moberg","year":"2019","unstructured":"Moberg KU, Handlin L, Kendall-Tackett K, Petersson M (2019) Oxytocin is a principal hormone that exerts part of its effects by active fragments. Med Hypotheses 133:109394\u20131093102. https:\/\/doi.org\/10.1016\/j.mehy.2019.109394","journal-title":"Med Hypotheses"},{"key":"4397_CR9","doi-asserted-by":"crossref","unstructured":"Burbach J, Young LJ, Russell J (2006) Oxytocin: synthesis, secretion, and reproductive functions. Knobil and Neill\u2019s physiology of reproduction. 3rd edn. pp 3055\u20133128","DOI":"10.1016\/B978-012515400-0\/50063-4"},{"key":"4397_CR10","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/ani13071207","volume":"13","author":"D Mota-Rojas","year":"2023","unstructured":"Mota-Rojas D, Marcet-Rius M, Dom\u00ednguez-Oliva A, Mart\u00ednez-Burnes J, Lezama-Garc\u00eda K, Hern\u00e1ndez-\u00c1valos I, Rodr\u00edguez-Gonz\u00e1lez D, Bienboire-Frosini C (2023) The role of Oxytocin in domestic animal\u2019s maternal care: parturition, bonding, and lactation. Animals 13:1207\u20131226. https:\/\/doi.org\/10.3390\/ani13071207","journal-title":"Animals"},{"key":"4397_CR11","doi-asserted-by":"publisher","first-page":"11465","DOI":"10.3390\/ijms222111465","volume":"22","author":"E Szczepanska-Sadowska","year":"2021","unstructured":"Szczepanska-Sadowska E, Wsol A, Cudnoch-Jedrzejewska A, \u017bera T (2021) Complementary role of Oxytocin and vasopressin in cardiovascular regulation. Int J Mol Sci 22:11465\u201311488. https:\/\/doi.org\/10.3390\/ijms222111465","journal-title":"Int J Mol Sci"},{"key":"4397_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-820107-7.00003-3","volume":"180","author":"F Althammer","year":"2021","unstructured":"Althammer F, Eliava M, Grinevich V (2021) Central and peripheral release of Oxytocin: relevance of neuroendocrine and neurotransmitter actions for physiology and behavior. Handb Clin Neurol 180:25\u201344. https:\/\/doi.org\/10.1016\/B978-0-12-820107-7.00003-3","journal-title":"Handb Clin Neurol"},{"key":"4397_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.yfrne.2009.05.004","volume":"30","author":"HE Ross","year":"2009","unstructured":"Ross HE, Young LJ (2009) Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front Neuroendocrinol 30:534\u2013547. https:\/\/doi.org\/10.1016\/j.yfrne.2009.05.004","journal-title":"Front Neuroendocrinol"},{"key":"4397_CR14","doi-asserted-by":"publisher","first-page":"102079","DOI":"10.1016\/j.npep.2020.102079","volume":"83","author":"O Abramova","year":"2020","unstructured":"Abramova O, Zorkina Y, Ushakova V, Zubkov E, Morozova A, Chekhonin V (2020) The role of Oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders. Neuropeptides 83:102079\u2013102094. https:\/\/doi.org\/10.1016\/j.npep.2020.102079","journal-title":"Neuropeptides"},{"key":"4397_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-neuro-102320-102847","volume":"44","author":"RC Froemke","year":"2021","unstructured":"Froemke RC, Young LJ (2021) Oxytocin, neural plasticity, and social behavior. Annu Rev Neurosci 44:359\u2013381. https:\/\/doi.org\/10.1146\/annurev-neuro-102320-102847","journal-title":"Annu Rev Neurosci"},{"key":"4397_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.peptides.2012.05.026","volume":"38","author":"O Erba\u015f","year":"2012","unstructured":"Erba\u015f O, Oltulu F, Ta\u015fkiran D (2012) Amelioration of rotenone-induced dopaminergic cell death in the striatum by Oxytocin treatment. Peptides 38:312\u2013317. https:\/\/doi.org\/10.1016\/j.peptides.2012.05.026","journal-title":"Peptides"},{"key":"4397_CR17","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1038\/s41598-021-85439-4","volume":"11","author":"SN Lee","year":"2021","unstructured":"Lee SN, Kraska J, Papargiris M, Teng L, Niranjan B, Hammar J, Ryan A, Frydenberg M, Lawrentschuk N, Middendorff R (2021) Oxytocin receptor antagonists as a novel Pharmacological agent for reducing smooth muscle tone in the human prostate. Sci Rep 11:6352\u20136362. https:\/\/doi.org\/10.1038\/s41598-021-85439-4","journal-title":"Sci Rep"},{"key":"4397_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3389\/fphar.2017.00673","volume":"8","author":"EJ Kim","year":"2017","unstructured":"Kim EJ, Jang M, Lee MJ, Choi JH, Lee SJ, Kim SK, Jang DS, Cho IH (2017) Schisandra chinensis stem ameliorates 3-nitropropionic acid-induced striatal toxicity via activation of the Nrf2 pathway and Inhibition of the MAPKs and NF-\u03baB pathways. Front Pharmacol 8:673\u2013689. https:\/\/doi.org\/10.3389\/fphar.2017.00673","journal-title":"Front Pharmacol"},{"key":"4397_CR19","doi-asserted-by":"publisher","unstructured":"Akman T, Akman L, Erbas O, Terek MC, Taskiran D, Ozsaran A (2015) The preventive effect of oxytocin to cisplatin-induced neurotoxicity: An experimental rat model. BioMed Res Int 2015: 1\u20135. https:\/\/doi.org\/10.1155\/2015\/167235","DOI":"10.1155\/2015\/167235"},{"key":"4397_CR20","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1177\/0269881110364269","volume":"25","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kalonia H, Kumar A (2011) Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington\u2019s-like symptoms: a comparative study. J Psychopharmacol 25:1399\u20131411. https:\/\/doi.org\/10.1177\/0269881110364269","journal-title":"J Psychopharmacol"},{"key":"4397_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11481-024-10149-3","volume":"19","author":"SS Mohamed","year":"2024","unstructured":"Mohamed SS, Rasheed NOA, Ibrahim WW, Shiha NA (2024) Targeting Toll-like receptor 4\/nuclear Factor-\u03baB and Nrf2\/Heme Oxygenase-1 crosstalk via Trimetazidine alleviates Lipopolysaccharide-Induced Depressive-like behaviors in mice. J Neuroimmune Pharmacol 19:50\u201363. https:\/\/doi.org\/10.1007\/s11481-024-10149-3","journal-title":"J Neuroimmune Pharmacol"},{"key":"4397_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.exger.2015.10.014","volume":"72","author":"VS Massicotte","year":"2015","unstructured":"Massicotte VS, Frara N, Harris MY, Amin M, Wade CK, Popoff SN, Barbe MF (2015) Prolonged performance of a high repetition low force task induces bone adaptation in young adult rats, but loss in mature rats. Exp Gerontol 72:204\u2013217. https:\/\/doi.org\/10.1016\/j.exger.2015.10.014","journal-title":"Exp Gerontol"},{"key":"4397_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s10753-021-01447-6","volume":"44","author":"AE Aziz","year":"2021","unstructured":"Aziz AE, Sayed AE, Sallam RH, El Sayed NA NS (2021) Neuroprotective effects of Telmisartan and Nifedipine against cuprizone-induced demyelination and behavioral dysfunction in mice: roles of NF-\u03baB and Nrf2. Inflammation 44:1629\u20131642. https:\/\/doi.org\/10.1007\/s10753-021-01447-6","journal-title":"Inflammation"},{"key":"4397_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"4397_CR25","unstructured":"Bancroft JD, Stevens A, Turner DR (1996) Theory and practice of histological techniques, 4th edn. Curchill Livingstone UK, pp 99\u2013112"},{"key":"4397_CR26","unstructured":"Bancroft JD, Gamble M (2008) Theory and practice of histological techniques, 6th edn. Curchill Livingstone UK"},{"key":"4397_CR27","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.3390\/cimb46060371","volume":"46","author":"MI Ionescu","year":"2024","unstructured":"Ionescu MI, Grigoras IF, Ionescu RB, Chitimus DM, Haret RM, Ianosi B, Ceanga M, Zagrean AM (2024) Oxytocin exhibits neuroprotective effects on Hippo Campal cultures under severe oxygen\u2013glucose deprivation conditions. Curr Issues Mol Biol 46:6223\u20136236. https:\/\/doi.org\/10.3390\/cimb46060371","journal-title":"Curr Issues Mol Biol"},{"key":"4397_CR28","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.020","volume":"27","author":"SE Moghadam","year":"2018","unstructured":"Moghadam SE, Tameh AA, Vahidinia Z, Atlasi MA, Bafrani HH, Naderian H (2018) Neuroprotective effects of Oxytocin hormone after an experimental stroke model and the possible role of calpain-1. J Stroke Cerebrovasc Dis 27:724\u2013732. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.10.020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4397_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/15321819.2021.1906270","volume":"42","author":"P Barahimi","year":"2021","unstructured":"Barahimi P, Karimian M, Nejati M, Azami Tameh A, Atlasi MA (2021) Oxytocin improves ischemic stroke by reducing expression of excitatory amino acid transporter 3 in rat MCAO model. J Immunoass Immunochem 42:513\u2013524. https:\/\/doi.org\/10.1080\/15321819.2021.1906270","journal-title":"J Immunoass Immunochem"},{"key":"4397_CR30","doi-asserted-by":"publisher","first-page":"115520","DOI":"10.1016\/j.biopha.2023.115520","volume":"167","author":"XY Fan","year":"2023","unstructured":"Fan XY, Shi G, Zhao YP, Yang JJ, Feng J (2023) Neuroprotective effects of Oxytocin against ischemic stroke in rats by blocking glutamate release and CREB-mediated DNA hypermethylation. Biomed Pharmacother 167:115520\u2013115529. https:\/\/doi.org\/10.1016\/j.biopha.2023.115520","journal-title":"Biomed Pharmacother"},{"key":"4397_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1006\/exnr.2000.7525","volume":"167","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Ferrante RJ, Dedeoglu A, Albers DW, Klivenyi P, Carlson EJ, Epstein CJ, Beal MF (2001) Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins Malonate, 3-nitropropionic acid, and MPTP. Exp Neurol 167:189\u2013195. https:\/\/doi.org\/10.1006\/exnr.2000.7525","journal-title":"Exp Neurol"},{"key":"4397_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/ijp.IJP_11_18","volume":"50","author":"S Mehan","year":"2018","unstructured":"Mehan S, Monga V, Rani M, Dudi R, Ghimire K (2018) Neuroprotective effect of Solanesol against 3-nitropropionic acid-induced Huntington\u2019s disease-like behavioral, biochemical, and cellular alterations: restoration of coenzyme-Q10-mediated mitochondrial dysfunction. Indian J Pharmacol 50:309\u2013319. https:\/\/doi.org\/10.4103\/ijp.IJP_11_18","journal-title":"Indian J Pharmacol"},{"key":"4397_CR33","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1080\/1028415X.2021.1913319","volume":"25","author":"M Salman","year":"2022","unstructured":"Salman M, Sharma P, Alam MI, Tabassum H, Parvez S (2022) Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington\u2019s disease like symptoms in rats. Nutr Neurosci 25:1898\u20131908. https:\/\/doi.org\/10.1080\/1028415X.2021.1913319","journal-title":"Nutr Neurosci"},{"key":"4397_CR34","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s11064-023-03868-1","volume":"48","author":"S Upadhayay","year":"2023","unstructured":"Upadhayay S, Yedke NG, Rahi V, Singh S, Kumar S, Arora A, Chandolia P, Kaur P, Kumar M, Koshal P (2023) An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a Huntington\u2019s disease model and its relevance to drug discovery and development. Neurochem Res 48:1631\u20131647. https:\/\/doi.org\/10.1007\/s11064-023-03868-1","journal-title":"Neurochem Res"},{"key":"4397_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","volume":"118","author":"HN Shalaby","year":"2018","unstructured":"Shalaby HN, El-Tanbouly DM, Zaki HF (2018) Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors. Food Chem Toxicol 118:227\u2013234. https:\/\/doi.org\/10.1016\/j.fct.2018.05.022","journal-title":"Food Chem Toxicol"},{"key":"4397_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/00207454.2020.1821677","volume":"132","author":"M Haider","year":"2022","unstructured":"Haider M, Salman M, Kaushik P, Bharadwaj N, Aggarwal NB, Tabassum H, Parvez S (2022) Chrysin ameliorates 3 Nitropropinoic acid induced neurotoxicity targeting behavioural, biochemical and histological alterations. Int J Neurosci 132:450\u2013458. https:\/\/doi.org\/10.1080\/00207454.2020.1821677","journal-title":"Int J Neurosci"},{"key":"4397_CR37","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s10787-022-01004-z","volume":"30","author":"WW Ibrahim","year":"2022","unstructured":"Ibrahim WW, Abdel Rasheed NO (2022) Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington\u2019s disease model in rats: emphasis on Sirt1\/Nrf2 signaling pathway. Inflammopharmacology 30:1745\u20131758. https:\/\/doi.org\/10.1007\/s10787-022-01004-z","journal-title":"Inflammopharmacology"},{"key":"4397_CR38","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1007\/s12035-022-02856-w","volume":"59","author":"RM Mansour","year":"2022","unstructured":"Mansour RM, El Sayed NS, Ahmed MA, El-Sahar AE (2022) Addressing peroxisome proliferator-activated receptor-gamma in 3-nitropropionic acid-induced striatal neurotoxicity in rats. Mol Neurobiol 59:4368\u20134383. https:\/\/doi.org\/10.1007\/s12035-022-02856-w","journal-title":"Mol Neurobiol"},{"key":"4397_CR39","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.toxrep.2015.08.004","volume":"2","author":"N Kaur","year":"2015","unstructured":"Kaur N, Jamwal S, Deshmukh R, Gauttam V, Kumar P (2015) Beneficial effect of rice Bran extract against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats. Toxicol Rep 2:1222\u20131232. https:\/\/doi.org\/10.1016\/j.toxrep.2015.08.004","journal-title":"Toxicol Rep"},{"key":"4397_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.physbeh.2015.12.015","volume":"155","author":"S Jamwal","year":"2016","unstructured":"Jamwal S, Kumar P (2016) Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: possible role of oxidative stress, neuroinflammation, and neurotransmitters. Physiol Behav 155:180\u2013187. https:\/\/doi.org\/10.1016\/j.physbeh.2015.12.015","journal-title":"Physiol Behav"},{"key":"4397_CR41","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s12035-016-9822-5","volume":"54","author":"S Jamwal","year":"2017","unstructured":"Jamwal S, Kumar P (2017) L-theanine, a component of green tea prevents 3-nitropropionic acid (3-NP)-induced striatal toxicity by modulating nitric oxide pathway. Mol Neurobiol 54:2327\u20132337. https:\/\/doi.org\/10.1007\/s12035-016-9822-5","journal-title":"Mol Neurobiol"},{"key":"4397_CR42","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/molecules28031402","volume":"28","author":"WA Mahdi","year":"2023","unstructured":"Mahdi WA, AlGhamdi SA, Alghamdi AM, Imam SS, Alshehri S, Almaniea MA, Hajjar BM, Al-Abbasi FA, Sayyed N, Kazmi I (2023) Neuroprotectant effects of Hibiscetin in 3-nitropropionic acid-induced Huntington\u2019s disease via subsiding oxidative stress and modulating monoamine neurotransmitters in rats brain. Molecules 28:1402\u20131414. https:\/\/doi.org\/10.3390\/molecules28031402","journal-title":"Molecules"},{"key":"4397_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0047-6374(00)00225-6","volume":"122","author":"G Segovia","year":"2001","unstructured":"Segovia G, Porras A, Del Arco A, Mora F (2001) Glutamatergic neurotransmission in aging: a critical perspective. Mech Ageing Dev 122:1\u201329. https:\/\/doi.org\/10.1016\/S0047-6374(00)00225-6","journal-title":"Mech Ageing Dev"},{"key":"4397_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnins.2015.00469","volume":"9","author":"J Lewerenz","year":"2015","unstructured":"Lewerenz J, Maher P (2015) Chronic glutamate toxicity in neurodegenerative diseases\u2014what is the evidence? Front Neurosci 9:469\u2013488. https:\/\/doi.org\/10.3389\/fnins.2015.00469","journal-title":"Front Neurosci"},{"key":"4397_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu QJ, Tymianski M (2018) Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain 11:1\u201314. https:\/\/doi.org\/10.1186\/s13041-018-0357-8","journal-title":"Mol Brain"},{"key":"4397_CR46","doi-asserted-by":"publisher","first-page":"797253","DOI":"10.3389\/fnmol.2021.797253","volume":"14","author":"S Chen","year":"2022","unstructured":"Chen S, Xu D, Fan L, Fang Z, Wang X, Li M (2022) Roles of N-methyl-D-aspartate receptors (NMDARs) in epilepsy. Front Mol Neurosci 14:797253\u2013797276. https:\/\/doi.org\/10.3389\/fnmol.2021.797253","journal-title":"Front Mol Neurosci"},{"key":"4397_CR47","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1523\/JNEUROSCI.23-12-05020.2003","volume":"23","author":"N Bizat","year":"2003","unstructured":"Bizat N, Hermel JM, Boyer F, Jacquard C, Cr\u00e9minon C, Ouary S, Escartin C, Hantraye P, Krajewski S, Brouillet E (2003) Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington\u2019s disease. J Neurosci 23:5020\u20135030. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-12-05020.2003","journal-title":"J Neurosci"},{"key":"4397_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2174\/138920009788898028","volume":"10","author":"A Camins","year":"2009","unstructured":"Camins A, Crespo-Biel N, Junyent F, Verdaguer E, Canudas AM, Pallas M (2009) Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium. Curr Drug Metab 10:433\u2013447. https:\/\/doi.org\/10.2174\/138920009788898028","journal-title":"Curr Drug Metab"},{"key":"4397_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuropharm.2008.09.012","volume":"56","author":"N Crespo-Biel","year":"2009","unstructured":"Crespo-Biel N, Camins A, Pallas M, Canudas A (2009) Evidence of calpain\/cdk5 pathway Inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro. Neuropharmacology 56:422\u2013428. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.09.012","journal-title":"Neuropharmacology"},{"key":"4397_CR50","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"E Brouillet","year":"2005","unstructured":"Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J Neurochem 95:1521\u20131540. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03515.x","journal-title":"J Neurochem"},{"key":"4397_CR51","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.neuropharm.2005.04.030","volume":"49","author":"N Bizat","year":"2005","unstructured":"Bizat N, Galas MC, Jacquard C, Boyer F, Hermel JM, Schiffmann S, Hantraye P, Blum D, Brouillet E (2005) Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves Inhibition of Calpain. Neuropharmacology 49:695\u2013702. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.04.030","journal-title":"Neuropharmacology"},{"issue":"3","key":"4397_CR52","doi-asserted-by":"publisher","first-page":"e33002","DOI":"10.1371\/journal.pone.0033002","volume":"7","author":"C Buddhala","year":"2012","unstructured":"Buddhala C, Suarez M, Modi J, Prentice H, Ma Z, Tao R, Wu JY (2012) Calpain cleavage of brain glutamic acid decarboxylase 65 is pathological and impairs GABA neurotransmission. PLoS ONE 7(3):e33002. https:\/\/doi.org\/10.1371\/journal.pone.0033002","journal-title":"PLoS ONE"},{"key":"4397_CR53","doi-asserted-by":"publisher","first-page":"109771","DOI":"10.1016\/j.intimp.2023.109771","volume":"116","author":"OE Mohamed","year":"2023","unstructured":"Mohamed OE, Abdallah DM, Fayez AM, Mohamed RA, El-Abhar HS (2023) Morin post-treatment surpassed Calpeptin in alameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate\/calpain axis, Kidins220, and BDNF\/TrkB\/AKT\/CREB trajectory. Int Immunopharmacol 116:109771\u2013109780. https:\/\/doi.org\/10.1016\/j.intimp.2023.109771","journal-title":"Int Immunopharmacol"},{"key":"4397_CR54","doi-asserted-by":"publisher","first-page":"17166","DOI":"10.1074\/jbc.M907757199","volume":"275","author":"GI Kusakawa","year":"2000","unstructured":"Kusakawa GI, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga SI (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275:17166\u201317172. https:\/\/doi.org\/10.1074\/jbc.M907757199","journal-title":"J Biol Chem"},{"key":"4397_CR55","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1074\/jbc.M610541200","volume":"282","author":"H Kamei","year":"2007","unstructured":"Kamei H, Saito T, Ozawa M, Fujita Y, Asada A, Bibb JA, Saido TC, Sorimachi H, Hisanaga SI (2007) Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J Biol Chem 282:1687\u20131694. https:\/\/doi.org\/10.1074\/jbc.M610541200","journal-title":"J Biol Chem"},{"key":"4397_CR56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/j.1471-4159.2003.02328.x","volume":"88","author":"SB Shelton","year":"2004","unstructured":"Shelton SB, Johnson GV (2004) Cyclin-dependent kinase\u20105 in neurodegeneration. J Neurochem 88:1313\u20131326. https:\/\/doi.org\/10.1111\/j.1471-4159.2003.02328.x","journal-title":"J Neurochem"},{"key":"4397_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-cellbio-092910-154023","volume":"27","author":"SC Su","year":"2011","unstructured":"Su SC, Tsai LH (2011) Cyclin-dependent kinases in brain development and disease. Annu Rev Cell Dev Biol 27:465\u2013491. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154023","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4397_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/biomedicines7040088","volume":"7","author":"R Roufayel","year":"2019","unstructured":"Roufayel R, Murshid N (2019) CDK5: key regulator of apoptosis and cell survival. Biomedicines 7:88\u2013100. https:\/\/doi.org\/10.3390\/biomedicines7040088","journal-title":"Biomedicines"},{"key":"4397_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2017.05.027","volume":"277","author":"H Zhang","year":"2017","unstructured":"Zhang H, Chang L, Zhang H, Nie J, Zhang Z, Yang X, Vuong AM, Wang Z, Chen A, Niu Q (2017) Calpain-2\/p35-p25\/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated Diphenyl ether-153. Toxicol Lett 277:41\u201353. https:\/\/doi.org\/10.1016\/j.toxlet.2017.05.027","journal-title":"Toxicol Lett"},{"key":"4397_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0896-6273(03)00191-0","volume":"38","author":"X Gong","year":"2003","unstructured":"Gong X, Tang X, Wiedmann M, Leslie B, Marshall J, Mao Z (2003) Cdk5-mediated Inhibition of the protective effects of transcription factor MEF-2 in neurotoxicity-induced apoprtosis. Neuron 38:33\u201346. https:\/\/doi.org\/10.1016\/s0896-6273(03)00191-0","journal-title":"Neuron"},{"key":"4397_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2007.05.038","volume":"421","author":"N Crespo-Biel","year":"2007","unstructured":"Crespo-Biel N, Camins A, Pelegr\u00ed C, Vilaplana J, Pall\u00e0s M, Canudas AM (2007) 3-Nitropropionic acid activates calpain\/cdk5 pathway in rat striatum. Neurosci Lett 421:77\u201381. https:\/\/doi.org\/10.1016\/j.neulet.2007.05.038","journal-title":"Neurosci Lett"},{"key":"4397_CR62","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I T\u00fanez","year":"2010","unstructured":"T\u00fanez I, Tasset I, P\u00e9rez-De La Cruz V, Santamar\u00eda A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15:878\u2013916. https:\/\/doi.org\/10.3390\/molecules15020878","journal-title":"Molecules"},{"key":"4397_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1527-3458.2006.00135.x","volume":"12","author":"A Camins","year":"2006","unstructured":"Camins A, Verdaguer E, Folch J, Pall\u00e0s M (2006) Involvement of Calpain activation in neurodegenerative processes. CNS Drug Rev 12:135\u2013148. https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00135.x","journal-title":"CNS Drug Rev"},{"key":"4397_CR64","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.neuro.2011.05.019","volume":"32","author":"H She","year":"2011","unstructured":"She H, Mao Z (2011) Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins. Neurotoxicology 32:563\u2013566. https:\/\/doi.org\/10.1016\/j.neuro.2011.05.019","journal-title":"Neurotoxicology"},{"key":"4397_CR65","doi-asserted-by":"publisher","first-page":"13650","DOI":"10.1073\/pnas.2232515100","volume":"100","author":"PD Smith","year":"2003","unstructured":"Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, O\u2019Hare MJ, Callaghan S, Slack RS, Przedborski S (2003) Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 100:13650\u201313655. https:\/\/doi.org\/10.1073\/pnas.2232515100","journal-title":"Proc Natl Acad Sci USA"},{"key":"4397_CR66","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1358\/dof.1998.023.07.858362","volume":"23","author":"P Yuen","year":"1998","unstructured":"Yuen P, Wang KK (1998) Calpain inhibitors: novel neuroprotectants and potential anticataract agents. Drugs Future 23:741\u2013750. https:\/\/doi.org\/10.1358\/dof.1998.023.07.858362","journal-title":"Drugs Future"},{"key":"4397_CR67","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1038\/sj.onc.1210079","volume":"26","author":"B Del Bello","year":"2007","unstructured":"Del Bello B, Moretti D, Gamberucci A, Maellaro E (2007) Cross-talk between Calpain and caspase-3\/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of Calpain Inhibition in cell death protection and p53 status. Oncogene 26:2717\u20132726. https:\/\/doi.org\/10.1038\/sj.onc.1210079","journal-title":"Oncogene"},{"key":"4397_CR68","first-page":"111","volume":"4","author":"AJ Markowitz","year":"2007","unstructured":"Markowitz AJ, White MG, Kolson DL, Jordan-Sciutto KL (2007) Cellular interplay between neurons and Glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration. Cellscience 4:111\u2013146. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2613343","journal-title":"Cellscience"},{"key":"4397_CR69","doi-asserted-by":"publisher","first-page":"25441","DOI":"10.1074\/jbc.M109.038174","volume":"284","author":"J Gafni","year":"2009","unstructured":"Gafni J, Cong X, Chen SF, Gibson BW, Ellerby LM (2009) Calpain-1 cleaves and activates caspase-7. J Biol Chem 284:25441\u201325449. https:\/\/doi.org\/10.1074\/jbc.M109.038174","journal-title":"J Biol Chem"},{"key":"4397_CR70","doi-asserted-by":"publisher","first-page":"13182","DOI":"10.1074\/jbc.M111.302612","volume":"287","author":"KH Yamada","year":"2012","unstructured":"Yamada KH, Kozlowski DA, Seidl SE, Lance S, Wieschhaus AJ, Sundivakkam P, Tiruppathi C, Chishti I, Herman I, Kuchay S (2012) Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress. J Biol Chem 287:13182\u201313193. https:\/\/doi.org\/10.1074\/jbc.M111.302612","journal-title":"J Biol Chem"},{"key":"4397_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0714-6","volume":"37","author":"J Zhu","year":"2018","unstructured":"Zhu J, Jin M, Wang J, Zhang H, Wu Y, Li D, Ji X, Yang H, Yin C, Ren T (2018) TNF\u03b1 induces Ca 2+ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells. J Exp Clin Cancer Res 37:1\u201312. https:\/\/doi.org\/10.1186\/s13046-018-0714-6","journal-title":"J Exp Clin Cancer Res"},{"key":"4397_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/abbi.1998.0748","volume":"356","author":"KK Wang","year":"1998","unstructured":"Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, Talanian RV, Keegan M, Herzog L, Allen H (1998) Caspase-mediated fragmentation of Calpain inhibitor protein Calpastatin during apoptosis. Arch Biochem Biophys 356:187\u2013196. https:\/\/doi.org\/10.1006\/abbi.1998.0748","journal-title":"Arch Biochem Biophys"},{"key":"4397_CR73","doi-asserted-by":"crossref","unstructured":"Gao G, Dou QP (2001) N-terminal cleavage of Bax by Calpain generates a potent proapoptotic 18\u2010kDa fragment that promotes bcl\u20102\u2010independent cytochrome C release and apoptotic cell death. J Cell Biochem 80:53\u201372. https:\/\/pubmed.ncbi.nlm.nih.gov\/11029754\/","DOI":"10.1002\/1097-4644(20010101)80:1<53::AID-JCB60>3.0.CO;2-E"},{"key":"4397_CR74","doi-asserted-by":"publisher","first-page":"27217","DOI":"10.1074\/jbc.M202945200","volume":"277","author":"S Gil-Parrado","year":"2002","unstructured":"Gil-Parrado S, Fern\u00e1ndez-Montalv\u00e1n A, Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch TA, Auerswald EA, Welsh K, Ree JC (2002) Ionomycin-activated Calpain triggers apoptosis: a probable role for Bcl-2 family members. J Biol Chem 277:27217\u201327226. https:\/\/doi.org\/10.1074\/jbc.M202945200","journal-title":"J Biol Chem"},{"key":"4397_CR75","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1046\/j.1471-4159.2001.00368.x","volume":"77","author":"WS Choi","year":"2001","unstructured":"Choi WS, Le EH, Chung CW, Jung YK, Jin BK, Kim SU, Oh TH, Saido TC, Oh YJ (2001) Cleavage of Bax is mediated by caspase-dependent or\u2010independent Calpain activation in dopaminergic neuronal cells: protective role of Bcl\u20102. J Neurochem 77:1531\u20131541. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00368.x","journal-title":"J Neurochem"},{"key":"4397_CR76","doi-asserted-by":"publisher","first-page":"16175","DOI":"10.1074\/jbc.M414552200","volume":"280","author":"J Takano","year":"2005","unstructured":"Takano J, Tomioka M, Tsubuki S, Higuchi M, Iwata N, Itohara S, Maki M, Saido TC (2005) Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from Calpastatin mutant mice. J Biol Chem 280:16175\u201316184. https:\/\/doi.org\/10.1074\/jbc.M414552200","journal-title":"J Biol Chem"},{"key":"4397_CR77","doi-asserted-by":"publisher","first-page":"26031","DOI":"10.1074\/jbc.M302833200","volume":"278","author":"M Sedarous","year":"2003","unstructured":"Sedarous M, Keramaris E, O\u2019Hare M, Melloni E, Slack RS, Elce JS, Greer PA, Park DS (2003) Calpains mediate p53 activation and neuronal death evoked by DNA damage. J Biol Chem 278:26031\u201326038. https:\/\/doi.org\/10.1074\/jbc.M302833200","journal-title":"J Biol Chem"},{"key":"4397_CR78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.tcb.2009.10.002","volume":"20","author":"D Speidel","year":"2010","unstructured":"Speidel D (2010) Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20:14\u201324. https:\/\/doi.org\/10.1016\/j.tcb.2009.10.002","journal-title":"Trends Cell Biol"},{"key":"4397_CR79","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0014-5793(02)02292-5","volume":"512","author":"T Choudhuri","year":"2002","unstructured":"Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G (2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512:334\u2013340. https:\/\/doi.org\/10.1016\/S0014-5793(02)02292-5","journal-title":"FEBS Lett"},{"key":"4397_CR80","doi-asserted-by":"publisher","first-page":"199","DOI":"10.22038\/ijbms.2017.8249","volume":"20","author":"M Mosadegh","year":"2017","unstructured":"Mosadegh M, Hasanzadeh S, Razi M (2017) Nicotine-induced damages in testicular tissue of rats; evidences for bcl-2, p53 and caspase-3 expression. Iran J Basic Med Sci 20:199\u2013208. https:\/\/doi.org\/10.22038\/ijbms.2017.8249","journal-title":"Iran J Basic Med Sci"},{"key":"4397_CR81","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.4161\/cc.8.11.8596","volume":"8","author":"AV Vaseva","year":"2009","unstructured":"Vaseva AV, Marchenko ND, Moll U (2009) The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle 8:1711\u20131719. https:\/\/doi.org\/10.4161\/cc.8.11.8596","journal-title":"Cell Cycle"},{"key":"4397_CR82","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1074\/jbc.274.2.787","volume":"274","author":"Y Han","year":"1999","unstructured":"Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR (1999) Tumor necrosis factor-\u03b1-inducible I\u03baB\u03b1 proteolysis mediated by cytosolic m-calpain: a mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-\u03bab activation. J Biol Chem 274:787\u2013794","journal-title":"J Biol Chem"},{"key":"4397_CR83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3892\/br.2016.785","volume":"5","author":"J Ji","year":"2016","unstructured":"Ji J, Su L, Liu Z (2016) Critical role of Calpain in inflammation. Biomed Rep 5:647\u2013652. https:\/\/doi.org\/10.3892\/br.2016.785","journal-title":"Biomed Rep"},{"key":"4397_CR84","doi-asserted-by":"publisher","first-page":"H833","DOI":"10.1152\/ajpheart.00893.2012","volume":"306","author":"X Li","year":"2014","unstructured":"Li X, Luo R, Chen R, Song L, Zhang S, Hua W, Chen H (2014) Cleavage of I\u03baB\u03b1 by Calpain induces myocardial NF-\u03baB activation, TNF-\u03b1 expression, and cardiac dysfunction in septic mice. Am J Physiol Heart Circ Physiol 306:H833\u2013H843. https:\/\/doi.org\/H-00893-2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4397_CR85","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1471-4159.2002.00824.x","volume":"81","author":"J Zhang","year":"2002","unstructured":"Zhang J, Krishnamurthy PK, Johnson GV (2002) Cdk5 phosphorylates p53 and regulates its activity. J Neurochem 81:307\u2013313. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00824.x","journal-title":"J Neurochem"},{"key":"4397_CR86","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2011.10.037","volume":"415","author":"Q Chen","year":"2011","unstructured":"Chen Q, Paillard M, Gomez L, Ross T, Hu Y, Xu A, Lesnefsky EJ (2011) Activation of mitochondrial \u00b5-calpain increases AIF cleavage in cardiac mitochondria during ischemia\u2013reperfusion. Biochem Biophys Res Commun 415:533\u2013538. https:\/\/doi.org\/10.1016\/j.bbrc.2011.10.037","journal-title":"Biochem Biophys Res Commun"},{"key":"4397_CR87","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nsb836","volume":"9","author":"H Ye","year":"2002","unstructured":"Ye H, Cande C, Stephanou NC, Jiang S, Gurbuxani S, Larochette N, Daugas E, Garrido C, Kroemer G, Wu H (2002) DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 9:680\u2013684. https:\/\/doi.org\/10.1038\/nsb836","journal-title":"Nat Struct Biol"},{"key":"4397_CR88","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.3390\/ijms22115444","volume":"22","author":"OO Gonchar","year":"2021","unstructured":"Gonchar OO, Maznychenko AV, Klyuchko OM, Mankovska IM, Butowska K, Borowik A, Piosik J, Sokolowska I (2021) C60 fullerene reduces 3-nitropropionic acid-induced oxidative stress disorders and mitochondrial dysfunction in rats by modulation of p53, Bcl-2 and Nrf2 targeted proteins. Int J Mol Sci 22:5444\u20135467. https:\/\/doi.org\/10.3390\/ijms22115444","journal-title":"Int J Mol Sci"},{"key":"4397_CR89","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/antiox10101628","volume":"10","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2021","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Or\u0161oli\u0107 N, Mandi\u0107 L, Sad\u017eak A, \u0160egota S (2021) Anti-oxidative, anti-inflammatory and anti-apoptotic effects of flavonols: targeting Nrf2, NF-\u03baB and p53 pathways in neurodegeneration. Antioxidants 10:1628\u20131673. https:\/\/doi.org\/10.3390\/antiox10101628","journal-title":"Antioxidants"},{"key":"4397_CR90","doi-asserted-by":"publisher","first-page":"937289","DOI":"10.3389\/fphar.2022.937289","volume":"13","author":"RL Li","year":"2022","unstructured":"Li RL, Wang LY, Duan HX, Zhang Q, Guo X, Wu C, Peng W (2022) Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases. Front Pharmacol 13:937289\u2013937318. https:\/\/doi.org\/10.3389\/fphar.2022.937289","journal-title":"Front Pharmacol"},{"key":"4397_CR91","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jcb.20748","volume":"98","author":"S Almeida","year":"2006","unstructured":"Almeida S, Brett AC, G\u00f3is IN, Oliveira CR, Rego AC (2006) Caspase-dependent and\u2010independent cell death induced by 3\u2010nitropropionic acid in rat cortical neurons. J Cell Biochem 98:93\u2013101. https:\/\/doi.org\/10.1002\/jcb.20748","journal-title":"J Cell Biochem"},{"key":"4397_CR92","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1471-4159.2009.06331.x","volume":"111","author":"R Lagoa","year":"2009","unstructured":"Lagoa R, Lopez-Sanchez C, Samhan\u2010Arias AK, Ga\u00f1an CM, Garcia-Martinez V, Gutierrez-Merino C (2009) Kaempferol protects against rat striatal degeneration induced by 3\u2010nitropropionic acid. J Neurochem 111:473\u2013487. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06331.x","journal-title":"J Neurochem"},{"key":"4397_CR93","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41401-020-00558-4","volume":"42","author":"X Yang","year":"2021","unstructured":"Yang X, Chu SF, Wang ZZ, Li FF, Yuan YH, Chen NH (2021) Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-\u03baB pathways in the striatum. Acta Pharmacol Sin 42:1409\u20131421. https:\/\/doi.org\/10.1038\/s41401-020-00558-4","journal-title":"Acta Pharmacol Sin"},{"key":"4397_CR94","doi-asserted-by":"publisher","first-page":"639571","DOI":"10.3389\/fphar.2021.639571","volume":"12","author":"C Li","year":"2021","unstructured":"Li C, Wang H, Wang M, Chen C, Bai F, Ban M, Wu C (2021) Oxytocin attenuates methamphetamine-induced apoptosis via Oxytocin receptor in rat hippocampal neurons. Front Pharmacol 12:639571\u2013639582. https:\/\/doi.org\/10.3389\/fphar.2021.639571","journal-title":"Front Pharmacol"},{"key":"4397_CR95","doi-asserted-by":"publisher","first-page":"337","DOI":"10.22074\/cellj.2022.7884","volume":"24","author":"S Momenabadi","year":"2022","unstructured":"Momenabadi S, Vafaei AA, Khorasani MZ, Vakili A (2022) Pre-ischemic Oxytocin treatment alleviated neuronal injury via suppressing NF-\u03baB, MMP-9, and apoptosis regulator proteins in a mice model of stroke. Cell J 24:337\u2013345. https:\/\/doi.org\/10.22074\/cellj.2022.7884","journal-title":"Cell J"},{"key":"4397_CR96","doi-asserted-by":"publisher","first-page":"25","DOI":"10.9790\/0853-141012536","volume":"14","author":"DG Mostafa","year":"2015","unstructured":"Mostafa DG, Khaleel EF, Abdel-Aleem GA (2015) Mechanism of action of Oxytocin as cardioprotection in rat model of myocardial infarction. IOSR J Dent Med Sci 14:25\u201336. https:\/\/doi.org\/10.9790\/0853-141012536","journal-title":"IOSR J Dent Med Sci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04397-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T16:44:49Z","timestamp":1750697089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04397-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4397"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04397-9","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research complies with the Guide for Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85\u2009\u2212\u200923, revised 2011) and was approved by the Ethics Committee for Animal Experimentation at Faculty of Pharmacy, Cairo University (Permit Number: PT 2863). Hard work was conducted to minimize suffering of the rats. This research does not contain any studies on humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"148"}}